CA1095833A - Controlled release pharmaceutical composition containing mono-sulfuric acid esters of higher fatty alcohols - Google Patents

Controlled release pharmaceutical composition containing mono-sulfuric acid esters of higher fatty alcohols

Info

Publication number
CA1095833A
CA1095833A CA283,403A CA283403A CA1095833A CA 1095833 A CA1095833 A CA 1095833A CA 283403 A CA283403 A CA 283403A CA 1095833 A CA1095833 A CA 1095833A
Authority
CA
Canada
Prior art keywords
composition according
surfactant
active agent
film
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA283,403A
Other languages
English (en)
French (fr)
Inventor
Dragan Hazler
John A. Hersey
Jean-Pierre Nougaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1095833A publication Critical patent/CA1095833A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA283,403A 1976-07-27 1977-07-25 Controlled release pharmaceutical composition containing mono-sulfuric acid esters of higher fatty alcohols Expired CA1095833A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH9588/76 1976-07-27
CH958876 1976-07-27

Publications (1)

Publication Number Publication Date
CA1095833A true CA1095833A (en) 1981-02-17

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
CA283,403A Expired CA1095833A (en) 1976-07-27 1977-07-25 Controlled release pharmaceutical composition containing mono-sulfuric acid esters of higher fatty alcohols

Country Status (27)

Country Link
JP (1) JPS5315411A (enrdf_load_html_response)
AR (1) AR216479A1 (enrdf_load_html_response)
AT (1) AT369987B (enrdf_load_html_response)
AU (1) AU515738B2 (enrdf_load_html_response)
BE (1) BE857122A (enrdf_load_html_response)
CA (1) CA1095833A (enrdf_load_html_response)
CY (1) CY1261A (enrdf_load_html_response)
DE (1) DE2732335C2 (enrdf_load_html_response)
DK (1) DK325677A (enrdf_load_html_response)
ES (1) ES461020A1 (enrdf_load_html_response)
FI (1) FI772217A7 (enrdf_load_html_response)
FR (1) FR2359607A1 (enrdf_load_html_response)
GB (1) GB1589982A (enrdf_load_html_response)
GR (1) GR65014B (enrdf_load_html_response)
HK (1) HK81884A (enrdf_load_html_response)
HU (1) HU178340B (enrdf_load_html_response)
IE (1) IE45534B1 (enrdf_load_html_response)
IL (1) IL52587A (enrdf_load_html_response)
KE (1) KE3441A (enrdf_load_html_response)
MY (1) MY8400057A (enrdf_load_html_response)
NL (1) NL176227C (enrdf_load_html_response)
NO (1) NO149874C (enrdf_load_html_response)
NZ (1) NZ184722A (enrdf_load_html_response)
PT (1) PT66850B (enrdf_load_html_response)
SE (1) SE437469B (enrdf_load_html_response)
SG (1) SG53884G (enrdf_load_html_response)
ZA (1) ZA774536B (enrdf_load_html_response)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (enrdf_load_html_response) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
NZ184722A (en) 1980-10-24
SE7708265L (sv) 1978-01-28
AU2730177A (en) 1979-02-01
NL7708162A (nl) 1978-01-31
IE45534B1 (en) 1982-09-22
NO772575L (no) 1978-01-30
JPS5726650B2 (enrdf_load_html_response) 1982-06-05
GB1589982A (en) 1981-05-20
AU515738B2 (en) 1981-04-30
DK325677A (da) 1978-01-28
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
HK81884A (en) 1984-11-25
BE857122A (fr) 1978-01-25
DE2732335C2 (de) 1983-01-20
DE2732335A1 (de) 1978-02-02
FR2359607A1 (fr) 1978-02-24
AT369987B (de) 1983-02-25
IL52587A (en) 1980-09-16
NL176227B (nl) 1984-10-16
PT66850B (fr) 1979-03-13
NO149874C (no) 1984-07-11
ZA774536B (en) 1979-02-28
KE3441A (en) 1984-09-14
ES461020A1 (es) 1979-05-01
AR216479A1 (es) 1979-12-28
NO149874B (no) 1984-04-02
NL176227C (nl) 1985-03-18
IL52587A0 (en) 1977-10-31
ATA541377A (de) 1982-07-15
JPS5315411A (en) 1978-02-13
MY8400057A (en) 1984-12-31
SE437469B (sv) 1985-03-04
SG53884G (en) 1985-03-08
FI772217A7 (enrdf_load_html_response) 1978-01-28
CY1261A (en) 1984-11-23
FR2359607B1 (enrdf_load_html_response) 1980-02-22
GR65014B (en) 1980-06-13
PT66850A (fr) 1977-08-01
DK325877A (da) 1978-01-20

Similar Documents

Publication Publication Date Title
US4610870A (en) Controlled release formulation
US4309405A (en) Sustained release pharmaceutical compositions
US4309404A (en) Sustained release pharmaceutical compositions
US7374781B2 (en) Sustained release formulations containing acetaminophen and tramadol
US4756911A (en) Controlled release formulation
US6190692B1 (en) Time-specific controlled release capsule formulations and method of preparing same
US4309406A (en) Sustained release pharmaceutical compositions
US4505890A (en) Controlled release formulation and method
US4728512A (en) Formulations providing three distinct releases
US4666705A (en) Controlled release formulation
CA1295247C (en) Sustained release capsule
EP0795324A2 (en) A pharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluids
KR880002673B1 (ko) 진통 캡슐제와 그 제조방법
RU97120754A (ru) Трехфазная фармацевтическая форма с постоянным и регулируемым высвобождением аморфного активного ингредиента для одноразового применения в сутки
CA1095833A (en) Controlled release pharmaceutical composition containing mono-sulfuric acid esters of higher fatty alcohols
CA2182004C (en) Film coated tablet of paracetamol and domperidone
MXPA97001465A (en) Formulation of acetaminofeno, liberacion sosten
GB2055577A (en) Substained release pharmaceutical compositions
JPH10147517A (ja) 高められた崩壊特性を有するフイルムコーテイングされた錠剤組成物
JPH11505542A (ja) 毎日一回投与するための、非晶質活性成分の一定のかつ制御された放出を行う三相型医薬製剤
US4291016A (en) Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
WO2009118764A1 (en) Pharmaceutical composition comprising diclofenac and paracetamol
PL192648B1 (pl) Preparat farmaceutyczny o kontrolowanym uwalnianiu, zawierający inhibitor ACE jako substancję aktywną
US20060147530A1 (en) Sustained release compositions containing alfuzosin
US4411882A (en) Galenical compositions

Legal Events

Date Code Title Description
MKEX Expiry